Erratum: Department of Error (Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial (2014) 383(9917) (603–613), (S0140673613619509), (10.1016/S0140-6736(13)61950-9));Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer:5-year results for local control and overall survival from the TARGIT-A randomised trial

The Lancet

Volumn 383, Issue 9917, 2014, Pages 603-613

  Vaidya, Jayant S ^a,b,f,g   Wenz, Frederik ^b   Bulsara, Max ^c,d   Tobias, Jeffrey S ^b,e   Joseph, David J ^d   Keshtgar, Mohammed ^b,f,g   Flyger, Henrik L ^h   Massarut, Samuele ⁱ   Alvarado, Michael ^k   Saunders, Christobel ^e,i,j   Eiermann, Wolfgang ^l   Metaxas, Marinos ^a   Sperk, Elena ^b   Sütterlin, Marc ^b   Brown, Douglas ^b   Esserman, Laura ^k   Roncadin, Mario ^b   Thompson, Alastair ^f   Dewar, John A ^m   Holtveg, Helle M R ^h   Pigorsch, Steffi ^n,o   Falzon, Mary ^b   Harris, Eleanor ^p   Matthews, April ^p,q   Brew Graves, Chris ^a   Potyka, Ingrid ^a   Corica, Tammy ^b   Williams, Norman R ^a   Baum, Michael ^a   more..

^a Institute of Sport   (United Kingdom)

^b Department of Radiation Oncology ^*  (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF NOTRE DAME   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Red Cross Hospital   (Germany)

^m NINEWELLS HOSPITAL   (United Kingdom)

ⁿ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^o EAST CAROLINA UNIVERSITY   (United States)

^p INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^q Independent Cancer Patients' Voice   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY EQUIPMENT; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TARGETED INTRAOPERATIVE RADIOTHERAPY; WHOLE BREAST RADIOTHERAPY; WOUND;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; INTRAOPERATIVE CARE; KAPLAN-MEIER ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 84893877736     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60218-X     Document Type: Erratum

References (47)

1. Darby S, McGale P, Correa C., et al, and the Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011; 378: 1707-16.
2. Fisher B, Bryant J, Dignam J.J., et al, and the National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20: 4141-49.
3. Fyles AW, McCready DR, Manchul L.A., et al Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004; 351: 963-70.
4. Pötter R., Gnant M, Kwasny W., et al, and the Austrian Breast and Colorectal Cancer Study Group. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 2007; 68: 334-40.
5. Hughes KS, Schnaper LA, Bellon J.R., et al Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 2013; 31: 2382-87.
6. Vaidya JS, Joseph DJ, Tobias J.S., et al Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010; 376: 91-102.
7. Vaidya JS, Vyas JJ, Mittra I, Chinoy RF Multicentricity and its influence on conservative breast cancer treatment strategy. Hong Kong International Cancer Congress; Hong Kong; Nov 17-19, 1995. Abstract 44.4.
8. Vaidya JS, Vyas JJ, Chinoy R.F., Merchant N., Sharma OP, Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 1996; 74: 820-24.
9. Baum M, Vaidya JS, Mittra I. Multicentricity and recurrence of breast cancer. Lancet 1997; 349: 208.
10. Athas WF, Adams-Cameron M, Hunt W.C., Amir-Fazli A, Key CR Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000; 92: 269-71.
11. Holland R, Veling SH, Mravunac M, Hendriks JH Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56: 979-90.
12. Vaidya JS, Baum M, Tobias J.S., et al Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 2001; 12: 1075-80.
13. Vaidya JS, Baum M, Tobias J.S., Morgan S., D'Souza D. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 2002; 28: 447-54.
14. Vaidya JS. A novel approach for local treatment of early breast cancer. PhD Thesis, University of London 2002 http://www.ucl.ac.uk/~rmhkjsv/papers/ thesis.htm.
15. Tobias JS, Vaidya JS, Keshtgar M, D'Souza DP, Baum M. Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. Br J Radiol 2004; 77: 279-84.
16. Herskind C, Steil V, Kraus-Tiefenbacher U, Wenz F. Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer. Radiat Res 2005; 163: 208-15.
17. Vaidya JS. Partial breast irradiation using targeted intraoperative radiotherapy (Targit). Nat Clin Pract Oncol 2007; 4: 384-85.
18. Enderling H, Chaplain MA, Anderson A.R., Vaidya JS A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol 2007; 246: 245-59.
19. Herskind C, Griebel J, Kraus-Tiefenbacher U, Wenz F. Sphere of equivalence-a novel target volume concept for intraoperative radiotherapy using low-energy X rays. Int J Radiat Oncol Biol Phys 2008; 72: 1575-81.
20. Herskind C, Wenz F. Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays. Strahlenther Onkol 2010; 186: 444-51.
21. Vaidya JS, Baum M, Tobias J.S., et al Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys 2011; 81: 1091-97.
22. Laster LL, Johnson MF, Kotler ML Non-inferiority trials: the 'at least as good as' criterion with dichotomous data. Stat Med 2006; 25: 1115-30.
23. Tunes da Silva G, Logan BR, Klein JP. Methods for equivalence and noninferiority testing. Biol Blood Marrow Transplant 2009; (suppl): 120-27.
24. Smits PC, Hofma S, Togni M., et al Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Lancet 2013; 381: 651-60.
25. Pocock SJ, Clayton TC, Altman DG Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002; 359: 1686-89.
26. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007; 13: 559-65.
27. Baum M, Chaplain MA, Anderson A.R., Douek M., Vaidya JS Does breast cancer exist in a state of chaos? Eur J Cancer 1999; 35: 886-91.
28. Keshtgar MR, Williams N, Corica T., Saunders C, Joseph D. Significantly better cosmetic outcome after intraoperative radiotherapy compared with external beam radiotherapy for early breast cancer: objective assessment of patients from a randomized controlled trial. Ann Surg Oncol 2011; S171.
29. Sperk E, Welzel G, Keller A., et al Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat 2012; 135: 253-60.
30. Welzel G, Boch A, Sperk E., et al Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol 2013; 8: 9.
31. Cuzick J, Stewart H, Peto R., et al Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15-29.
32. Darby SC, Ewertz M, McGale P., et al Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987-98.
33. Offersen BV, Overgaard M, Kroman N., Overgaard J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 2009; 90: 1-13.
34. Kraus-Tiefenbacher U., Bauer L, Scheda A., et al Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys 2006; 66: 377-81.
35. Liu Q, Schneider F, Ma L., Wenz F, Herskind C. Relative Biologic Effectiveness (RBE) of 50 kV X-rays measured in a phantom for intraoperative tumor-bed irradiation. Int J Radiat Oncol Biol Phys 2013; 85: 1127-33.
36. Veronesi U, Orecchia R, Luini A., et al Full dose intraoperative radiotherapy with electrons (ELIOT) during breast conserving surgery: experience with 1246 cases. Ecancermedicalscience 2008; 2: 65.
37. Belletti B, Vaidya JS, D'Andrea S, et al Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res 2008; 14: 1325-32.
38. Vaidya JS, Baldassarre G, Massarut S. Beneficial effects of intraoperative radiotherapy on tumor microenvironment could improve outcomes. Int J Radiat Oncol Biol Phys 2009; 74: 976.
39. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757-70.
40. Clarke M, Collins R, Darby S., et al, and the Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
41. Alvarado M, Connolly J, Oboite M., Moore D, Park C, Esserman L. Patient preference for choosing intra-operative or external-beam radiotherapy following breast conservation. Eur J Cancer 2010; 8 (suppl): 2.
42. Corica T, Nowak A, Saunders C., Bulsara M, Joseph D. Patient preferences for adjuvant radiotherapy in early breast cancer - an Australian sub-study of the International TARGIT Trial. Eur J Cancer 2012; 48 (suppl 1): S187.
43. Blamey RW, Bates T, Chetty U., et al Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer 2013; 49: 2294-302.
44. Polgár C., Van Limbergen E, Pötter R, et al., and the GEC-ESTRO breast cancer working group. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010; 94: 264-73.
45. Smith BD, Arthur DW, Buchholz T.A., et al Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 987-1001.
46. Vaidya JS, Tobias JS, Baum M, et al Intraoperative radiotherapy for breast cancer. Lancet Oncol 2004; 5: 165-73.
47. Alvarado M, Ozanne E, Mohan A., Esserman L. Cost-effectiveness of intraoperative radiation therapy for breast conservation. J Clin Oncol 2011; 29 (suppl): 6081 (abstr).